Table 3

1-Year Event Rates in Patients Randomized to Bivalirudin or Heparin Plus GPI, According to Risk Category

BivalirudinHeparin Plus GPIp ValueInteraction
Death
 Low risk3 (0.4%)9 (1.2%)0.0870.275
 Intermediate risk11 (4.2%)11 (4.1%)0.993
 High risk19 (8.4%)40 (15.9%)0.0139
Non-CABG major bleeding
 Low risk23 (3.0%)53 (6.9%)0.00050.311
 Intermediate risk19 (7.2%)26 (9.8%)0.281
 High risk29 (12.9%)45 (17.9%)0.135
Reinfarction
 Low risk24 (3.2%)22 (2.9%)0.7230.172
 Intermediate risk12 (4.5%)12 (4.5%)0.993
 High risk8 (3.6%)20 (7.9%)0.042
Stent thrombosis
 Low risk21 (2.8%)20 (2.6%)0.8340.400
 Intermediate risk15 (5.7%)11 (4.1%)0.416
 High risk5 (2.2%)10 (4.0%)0.275
Target vessel revascularization
 Low risk49 (6.5%)38 (5.0%)0.1970.635
 Intermediate risk27 (10.2%)16 (6.0%)0.078
 High risk16 (7.1%)16 (6.3%)0.740

Values are presented as n (%) unless otherwise noted. Low risk (n = 1,522), intermediate risk (n = 531), and high risk (n = 477).

Abbreviations as in Tables 1 and 2.